Skip to main content
Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
303.01
+5.08 (1.71%)
At close: Feb 21, 2025, 4:00 PM
301.90
-1.11 (-0.37%)
After-hours: Feb 21, 2025, 6:29 PM EST

Amgen Revenue by Type
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 3, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
Product Sales
32.03B 31.14B 29.54B 28.18B 26.91B 25.63B 25.32B 24.92B
Product Sales Growth
19.01% 21.51% 16.68% 13.11% 8.50% 4.52% 2.91% 1.96%
Other
1.40B 1.39B 1.39B 1.35B 1.28B 1.20B 1.26B 1.27B
Other Growth
9.14% 15.45% 10.21% 5.97% -15.90% -33.48% -29.03% -32.23%

Product Sales by Geography
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 3, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
United States
23.30B 22.66B 21.37B 20.27B 19.27B 18.20B 17.97B 17.68B
United States Growth
20.91% 24.54% 18.94% 14.64% 8.62% 4.57% 2.74% 1.50%
Rest of World
8.73B 8.48B 8.17B 7.91B 7.64B 7.43B 7.35B 7.24B
Rest of World Growth
14.23% 14.10% 11.15% 9.36% 8.22% 4.40% 3.32% 3.12%

Operating Expense Breakdown
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 3, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
Selling, General, and Administrative
7.10B 7.49B 7.22B 6.73B 6.18B 5.48B 5.41B 5.44B
Selling, General, and Administrative Growth
14.84% 36.79% 33.43% 23.60% 14.13% 3.99% 2.38% 1.91%
Research and Development
5.96B 5.77B 5.40B 5.07B 4.78B 4.57B 4.61B 4.53B
Research and Development Growth
24.67% 26.24% 17.28% 11.82% 7.89% 2.60% -3.38% -5.78%
Other Expenses
248.00M 192.00M 765.00M 836.00M 879.00M 840.00M 201.00M 661.00M
Other Expenses Growth
-71.79% -77.14% 280.60% 26.48% 74.75% 42.86% -65.04% -59.40%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.